9vc

9vc is a tech-enabled biotech VC that creates, augments, and invests in companies with late-stage drug development programs.

Venture Capital Active null, Israel
Visit website ↗ LinkedIn
Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—

About

9vc utilizes technology to create, augment, and invest in companies focused on late-stage drug development programs. Their approach, described as "reincarnation," aims to bring drugs to patients and value to investors quickly and with lower risk. They achieve this by morphing untapped late clinical stage drugs and grafting them onto promising companies or establishing new ones. The firm combines technology and experience, using a proprietary search engine and tech bio partnerships for diligence and development. Their team comprises experienced biotech and pharma builders, investors, and senior executives with a proven track record.

Portfolio

No portfolio companies in this dataset yet.

Q&A

What is 9vc's primary investment focus?
9vc is a tech-enabled biotech VC fund.
Where is 9vc headquartered?
9vc is headquartered in Israel.
Who are the co-founders of 9vc?
The co-founders of 9vc are Jan Schultink and Anat Naschitz.
Who is the Managing Partner at 9vc?
Anat Naschitz is the Co-founder & Managing Partner at 9vc.
Does 9vc have an advisory board?
Yes, Danny Bar-Zohar is a member of the Advisory Board of 9vc.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)